{"transactions":[{"id":742772,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-10T20:31:39.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested."}],"balance_after":500000,"derivative":{"exercise_price":0.25,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001731122-26-000835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000835/ownership.xml","form_type":"4"}},{"id":1015741,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-10-20T20:20:47.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001406/ownership.xml","form_type":"4"}},{"id":1015740,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-20T20:15:20.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters."},{"field":"security","element":"securityTitle","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":15000,"derivative":{"exercise_price":13.6,"expiration_date":"2027-04-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001731122-25-001405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001405/ownership.xml","form_type":"4"}},{"id":1015739,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-20T20:15:20.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"SNS Universal Solutions LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"SNS Universal Solutions LLC is an entity which the Reporting Person controls."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001731122-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112225001405/ownership.xml","form_type":"4"}},{"id":1884153,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":39583,"kind":"person","name":"Caple Frederick William","position":1,"cik":"0001978199","reported_name":"Caple Frederick William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-19T18:06:42.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By SNS Universal Solutions, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle."}],"balance_after":125000,"derivative":{"exercise_price":1.26,"expiration_date":"2033-05-01","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112223000987/ownership.xml","form_type":"4"}}]}